$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
08:05pm, Friday, 07'th Aug 2020
GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it has completed its previously announced offering of $450 million i
Clovis (CLVS) Q2 Earnings Lag, Revenues Show Coronavirus Impact
03:44pm, Friday, 07'th Aug 2020
Clovis (CLVS) reports dismal second-quarter 2020 results. Sales of the company's sole marketed drug, Rubraca, decline sequentially. Shares down.
Top Ranked Momentum Stocks to Buy for August 7th
12:03pm, Friday, 07'th Aug 2020
Top Ranked Momentum Stocks to Buy for August 7th
Coronavirus Pandemic Fuels Big Gains In Biotech Stocks; Too Extended To Buy?
12:00pm, Friday, 07'th Aug 2020
Biotech stocks make headlines on an almost daily basis as the world rushes to find a coronavirus treatment or vaccine.
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
12:00am, Friday, 07'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 6)
ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting...
Emergent BioSolutions: The Indirect COVID-19 Vaccine Play Looks Undervalued (NYSE:EBS)
05:37pm, Thursday, 06'th Aug 2020
The manufacturing deals for candidates set the stage for Emergent to ride the momentum of COVID-19 vaccine development.
Emergent Biosolutions (EBS) is an Incredible Growth Stock: 3 Reasons Why
04:45pm, Thursday, 06'th Aug 2020
Emergent Biosolutions (EBS) could produce exceptional returns because of its solid growth attributes.
Emergent BioSolutions' Shares March Higher, Can It Continue?
02:34pm, Thursday, 06'th Aug 2020
As of late, it has definitely been a great time to be an investor in Emergent BioSolutions.
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions
02:22am, Wednesday, 05'th Aug 2020
Moody's Investors Service ("Moody's") assigned first-time ratings to Emergent BioSolutions Inc. ("Emergent") including a Ba2 Corporate Family Rating, a Ba2-PD Probability of Default Rating, a Ba3 seni
Emergent BioSolutions Announces Upsize and Pricing of $450 Million of 3.875% Senior Unsecured Notes Due 2028
10:31pm, Tuesday, 04'th Aug 2020
GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it has priced its offering of $450 million aggregate principal amoun
Lion Biotechnologies Reaches 80-Plus Relative Strength Rating Benchmark
09:33pm, Tuesday, 04'th Aug 2020
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.
Emergent BioSolutions Announces Proposed Offering of $400 Million of Senior Unsecured Notes
12:00pm, Tuesday, 04'th Aug 2020
GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it intends to offer $400 million aggregate principal amount of senio
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
Jim Cramer: 'Stop saying the market makes no sense'
11:05pm, Monday, 03'rd Aug 2020
"When the pandemic's out of control, you better believe the Cramer Covid-19 Index will lead us higher," CNBC's Jim Cramer said.
Sign In
Buy EBS